{"status":"OK","data":{"advertisement":{"id":198688,"title":"1/FENG-G/2023","partial_offer_allowed":false,"publication_date":"2023-03-23","submission_deadline":"2023-04-24 23:59:59","planned_sign_date":null,"supplementary_orders":null,"terms_of_contract_change":"1. Wszelkie zmiany w umowie, kt\u00f3ra zostanie zawarta w wyniku post\u0119powania, wymagaj\u0105 formy pisemnej, pod rygorem niewa\u017cno\u015bci. \n2. Zamawiaj\u0105cy dopuszcza zmian\u0119 umowy w formie aneksu w sytuacji, kiedy nast\u0105pi ustawowa zmiana stawki VAT.\n\n1. All modification to the agreement, which will be concluded as a result of the proceeding, must be in writing under pain of nullity.\n2. The Ordering Party allows for amendments to the agreement in the form of an annex in a situation where a statutory change in the VAT rate occurs.","created_at":"2023-03-23 13:41:13","modified_at":"2023-04-25 00:00:04","contact_persons":[{"id":3621,"forename":"Ma\u0142gorzata","surname":"S\u0119ktas","phone_number":"+48 22 5936277","email":"m.sektas@cellis.eu","created_by":null,"created_at":"2026-03-20 13:48:06","modified_at":"2026-03-20 13:48:06","modified_by":null}],"orders":[{"id":328843,"estimated_value":null,"order_items":[{"id":373182,"description":"Badania in vivo i ex vivo poszukiwania marker\u00f3w odpowiedzi.\n1) Zbadanie wp\u0142ywu terapii makrofagami za\u0142adowanymi bia\u0142kiem no\u015bnikowym po\u0142\u0105czonym z lekiem (MDC-735) na populacje i fenotyp kom\u00f3rek zlokalizowanych w mikro\u015brodowisku guza.\n2) Zbadanie wp\u0142ywu terapii makrofagami za\u0142adowanymi bia\u0142kiem no\u015bnikowym po\u0142\u0105czonym z lekiem (MDC-735) na produkcj\u0119 cytokin/chemokin w pr\u00f3bkach od maksymalnie 10 pacjent\u00f3w z glejakiem.\nSzczeg\u00f3\u0142owy opis eksperyment\u00f3w do wykonania przez wykonawc\u0119 zawiera Za\u0142\u0105cznik nr 1\n\u201eFORMULARZ OFERTOWY do zapytania ofertowego nr. 1/FENG-G/2023\u201d\n\nIn vivo and ex vivo research for markers of response.\n1) To investigate the effect of therapy with macrophages loaded with drug-linked carrier protein (MDC-735) on the population and phenotype of cells located in the tumor microenvironment.\n2) To investigate the effect of macrophage therapy loaded with a drug-linked carrier protein (MDC-735) on cytokine/chemokine production in samples from up to 10 glioblastoma patients.\nDetailed experiments to be done by the contractor are performed in the Appendix 1 \n\u201eBID FORM for request for request for quotation no. 1/FENG-G/2023\u201d\n\n","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"\u017boliborz","locality":"Warszawa","created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"id":420374,"type":{"id":1,"name":"adres"},"group_uuid":"3f995725-15a2-4624-bd6d-9468f118bab0"}],"participation_conditions":[{"id":1015093,"description":"Wykonawca musi posiada\u0107 niezb\u0119dn\u0105 wiedz\u0119 i do\u015bwiadczenie, w tym:\na) udokumentowane do\u015bwiadczenie w prowadzeniu eksperyment\u00f3w na modelach glejaka potwierdzone przez udzia\u0142 w co najmniej dw\u00f3ch projektach/zam\u00f3wieniach w przeci\u0105gu ostatnich dw\u00f3ch lat,\n b) niezb\u0119dn\u0105 wiedz\u0119 i do\u015bwiadczenie potwierdzone wydaniem co najmniej dw\u00f3ch publikacji naukowych \nw temacie terapii glejaka w przeci\u0105gu ostatnich dw\u00f3ch lat,\n c) do\u015bwiadczenie w prowadzeniu eksperyment\u00f3w ex vivo na pr\u00f3bkach pozyskanych od pacjent\u00f3w \nw celu wytypowania marker\u00f3w wczesnej odpowiedzi biologicznej na leczenie,\nd) do\u015bwiadczenie z mysimi modelami glejaka (np. CT2A, GL261),\ne) do\u015bwiadczenie w cytometrii przep\u0142ywowej,\nf) do\u015bwiadczenie w wykonywaniu bada\u0144 przedklinicznych r\u00f3wnie\u017c dla partner\u00f3w komercyjnych.\n\nContractors participating in the proceedings must fulfil following conditions: \n1) must have the necessary knowledge and experience, including:\na) documented experience in conducting experiments on glioblastoma models confirmed by participation in at least two projects/contracts within the last two years,\n b) necessary knowledge and experience confirmed by at least two scientific publications in the field of glioblastoma therapy in the last two years,\n c) experience in conducting ex vivo experiments on samples obtained from patients to select markers of early biological response to a treatment,\nd) experience with glioma mouse models (e.g. CT2A, GL261),\ne) experience in flow cytometry,\nf) experience in performing pre-clinical studies also for commercial partner.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"9e359783-db40-42c4-85ec-46a6bf17f359"},{"id":1015094,"description":"Wykonawca musi posiada\u0107 potencja\u0142 techniczny, w tym:\nlaboratorium wyposa\u017cone w aparatur\u0119 niezb\u0119dn\u0105 do wykonania zam\u00f3wienia i dost\u0119p do zwierz\u0119tarni.\n\nContractor must have technical potential, including:\na laboratory equipped with the equipment necessary to perform the contract and access to the animal facility.","type":{"id":3,"name":"Potencja\u0142 techniczny"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"b6dafa7e-4b00-4b63-af39-37b2d1d01460"},{"id":1015095,"description":"Wykonawca musi posiada\u0107 dost\u0119p do pacjent\u00f3w z glejakiem w celu pobrania pr\u00f3bek guza bezpo\u015brednio od pacjent\u00f3w i wykorzystania do bada\u0144.\n\nContractor must have access to glioblastoma patients to collect tumor samples directly from patients and use them for research.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"82357304-ff8c-4a05-a236-68f38c2bf76c"},{"id":1015096,"description":"Wykonawca nie mo\u017ce by\u0107 powi\u0105zany osobowo lub kapita\u0142owo z Zamawiaj\u0105cym. \nPrzez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy beneficjentem lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu beneficjenta lub osobami wykonuj\u0105cymi w imieniu beneficjenta czynno\u015bci zwi\u0105zane z przeprowadzeniem procedury wyboru wykonawcy a wykonawc\u0105, polegaj\u0105ce w szczeg\u00f3lno\u015bci na:\na)\tuczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej,\nb)\tposiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji, o ile ni\u017cszy pr\u00f3g nie wynika z przepis\u00f3w prawa,\nc)\tpe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika\nd)\tpozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa  lub powinowactwa w linii prostej, pokrewie\u0144stwa drugiego stopnia lub powinowactwa drugiego stopnia w linii bocznej \nlub w stosunku przysposobienia, opieki lub kurateli albo pozostawaniu we wsp\u00f3lnym po\u017cyciu z wykonawc\u0105, jego zast\u0119pc\u0105 prawnym lub cz\u0142onkami organ\u00f3w zarz\u0105dzaj\u0105cych lub organ\u00f3w nadzorczych wykonawc\u00f3w ubiegaj\u0105cych si\u0119 o udzielenie zam\u00f3wienia, \ne)\tpozostawaniu z wykonawc\u0105 w takim stosunku prawnym lub faktycznym, \u017ce istnieje uzasadniona w\u0105tpliwo\u015b\u0107 co do ich bezstronno\u015bci lub niezale\u017cno\u015bci w zwi\u0105zku z post\u0119powaniem o udzielenie zam\u00f3wienia.\n\nOferent zobowi\u0105zany jest z\u0142o\u017cy\u0107 stosowne o\u015bwiadczenie zawarte w Za\u0142\u0105czniku 3 do Zapytania ofertowego 1/FENG-G/2023.\n\nThe Contractor may not be personally, or equity related to the Ordering Party.\nEquity or personal relationship is understood as relations between the Ordering Party or individuals authorized to take commitments on behalf of the Ordering Party or those acting on behalf of the Ordering Party in order to prepare and implement the contract award procedure, and the Contractor, including in particular:\na)\tBeing a partner to civil law partnership or commercial law partnership,\nb)\tHolding at least 10% of shares, if lower threshold does not result from law,\nc)\tBeing a member of a supervisory or management corporate body, a holder of general commercial power of attorney, an authorised representative,\nd)\tBeing married to, being in direct consanguinity or affinity, second degree consanguinity or affinity of the second degree collaterally or by adoption or guardianship or being in cohabitation with the Contractor, its legal representative or members of management or supervisory bodies of economic operators competing for the contract award,\ne)\tbeing in such a legal or factual relationship with the Contractor that there is a reasonable doubt as to their impartiality or independence in connection with the contract award procedure.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"0dce94a7-50d8-4c9d-b944-cf447ca2c1f9"},{"id":1015097,"description":"Wykonawca musi znajdowa\u0107 si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej czasowe i zgodne z wymaganiami stawianymi w zapytaniu ofertowym wykonanie zam\u00f3wienia.\n\nContractor must be in an economic and financial situation ensuring timely execution of the order and in accordance with the requirements set out in the request for quotation.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"bd3a40b4-939b-4a54-a1b1-ff12ed85345c"},{"id":1015098,"description":"1. Ka\u017cdy Oferent mo\u017ce z\u0142o\u017cy\u0107 jedn\u0105 ofert\u0119.\n2. Oferta musi by\u0107 z\u0142o\u017cona na Formularzu ofertowym (Za\u0142\u0105cznik 1 do Zapytania ofertowego 1/FENG-G/2023). Oferta musi by\u0107 parafowana i podpisana przez nale\u017cycie umocowanego przedstawiciela Oferenta. W przypadku podpisania oferty przez osob\u0119 niewymienion\u0105 w dokumencie rejestrowym (ewidencyjnym) Oferenta, nale\u017cy do oferty do\u0142\u0105czy\u0107 stosowne pe\u0142nomocnictwo.\n3. Oferent zobowi\u0105zany jest z\u0142o\u017cy\u0107 wraz z ofert\u0105 aktualny odpis z krajowego rejestru s\u0105dowego lub z centralnej ewidencji i informacji o dzia\u0142alno\u015bci gospodarczej, wystawiony nie wcze\u015bniej ni\u017c trzy (3) miesi\u0105ce przed up\u0142ywem terminu sk\u0142adania ofert, w celu wykazania braku podstaw do wykluczenia. \n\n1. Each Bidder may submit only one offer.\n2. Offer should be prepared in the bid form (Appendix 1 to the request for quotation 1/FENG-G/2023). \nThe offer must be initialled and signed by the authorised representative of the Bidder.\nIf the offer would be signed by the person not listed in registered documents of the Contractor, the offer shall be accompanied by the appropriate power of attorney.\n3. Contractor must submit with the offer copy (scan) of relevant Register of Business Activity, applicable to country of residence of Contractor, issued not earlier than three (3) months before the deadline for submission the offer to demonstrate the absence of grounds for exclusion.","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"7368c8d0-cd51-4361-a017-0d0eaf85f360"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"0cf511be-1593-4d1f-9c61-55e078fdb6de"}],"evaluation_criteria":[{"id":571623,"price_criterion":true,"description":"\u2022\tCena \u2013 80 %\nKryterium \u201eCena\u201d oceniane b\u0119dzie nast\u0119puj\u0105co: \nPi(C) \u2013 liczba punkt\u00f3w jakie otrzyma oferta \u201ei\u201d za kryterium \u201eCena\u201d\nCmin \u2013 najni\u017csza cena spo\u015br\u00f3d wszystkich wa\u017cnych i nieodrzuconych ofert\nCi \u2013 cena oferty \u201ei\u201d \nPi(C) = (Cmin : Ci) x 80\nW kryterium Cena Oferent mo\u017ce uzyska\u0107 80 pkt","created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"06217984-86df-4191-aeb9-ce08914c213c"},{"id":571624,"price_criterion":false,"description":"\u2022\tTermin realizacji zam\u00f3wienia \u2013 20%\nKryterium \u201eTermin realizacji zam\u00f3wienia\u201d oceniane b\u0119dzie \nw nast\u0119puj\u0105cy spos\u00f3b: \n1 \u2013 4 miesi\u0105ce \u2013 20 punkt\u00f3w\n5 \u2013 7 miesi\u0119cy \u2013 10 punkt\u00f3w\n8 \u2013 10 miesi\u0119cy \u2013 5 punkt\u00f3w\n11 \u2013 12 miesi\u0119cy \u2013 0 punkt\u00f3w","created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null,"group_uuid":"dda3df0e-f07d-4d22-9c77-584a31df54eb"}],"is_variant":false,"title":"Badania in vivo i ex vivo poszukiwania marker\u00f3w odpowiedzi","order_node":{"id":250206},"created_by":null,"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":null}],"created_by":{"id":4346,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Cellis Sp. z o.o.","identification_number_type":"nip","identification_number":"5252640606","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"\u017boliborz","locality":"Warszawa","created_by":{"id":4346,"contact_persons":[]},"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":{"id":4346,"contact_persons":[]},"id":516858,"street":"Genera\u0142a Zaj\u0105czka","number_description":"28","postcode":"01-510"},"created_by":{"id":4346,"contact_persons":[]},"created_at":"2023-03-23 13:41:13","modified_at":"2023-03-23 13:41:13","modified_by":{"id":4346,"contact_persons":[]},"id":199137},"advertisement":{"id":151542,"number":"2023-4346-151542","publication_date":"2023-03-22","created_by":{"id":4346,"contact_persons":[]},"created_at":"2023-03-22 18:23:21","modified_at":"2023-04-25 00:00:04","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[198462,198688],"enrollment":{"id":36465,"name":"Rozw\u00f3j prze\u0142omowej terapii kom\u00f3rkowej MDC-735 w glejaku z pierwsz\u0105 wznow\u0105","number":"001/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-001/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-03-22 17:09:11","modified_at":"2023-03-22 17:09:11","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":198462,"publication_date":"2023-03-22"},"id":949995,"name":"Zapytanie ofertowe 1/FENG-G/2023","file":{"id":1059145,"name":"Zapytanie ofertowe_1_FENG-G_2023_2023.02.22.pdf","created_at":"2023-03-23 13:41:13","created_by":{"forename":"Ma\u0142gorzata","surname":"S\u0119ktas"},"uri":"/api/files/1059145"},"group_uuid":"04507841-1267-491b-a00d-4132f90032d7"},{"origin":{"id":198462,"publication_date":"2023-03-22"},"id":949996,"name":"Request for Quotation 1/FENG-G/2023","file":{"id":1059146,"name":"Request for quotation_1_FENG-G_2023_2023.02.22.pdf","created_at":"2023-03-23 13:41:13","created_by":{"forename":"Ma\u0142gorzata","surname":"S\u0119ktas"},"uri":"/api/files/1059146"},"group_uuid":"84ce0aec-5e0b-4e95-a409-91ae94df0244"},{"origin":{"id":198688,"publication_date":"2023-03-23"},"id":951174,"name":"Informacja zmianie do zapytania 1FENG-G2023","file":{"id":1060399,"name":"Zmiana do zapytania 1FENG-G2023_23.03.2023.pdf","created_at":"2023-03-23 13:38:48","created_by":{"forename":"Ma\u0142gorzata","surname":"S\u0119ktas"},"uri":"/api/files/1060399"},"group_uuid":"a052ad6c-4fed-454d-8e32-299e74ba58ab"},{"origin":{"id":198688,"publication_date":"2023-03-23"},"id":951175,"name":"Information about the change to the request 1FENG-G2023","file":{"id":1060402,"name":"Change to the Request for quotation 1FENG-G2023_23.03.2023.pdf","created_at":"2023-03-23 13:39:29","created_by":{"forename":"Ma\u0142gorzata","surname":"S\u0119ktas"},"uri":"/api/files/1060402"},"group_uuid":"772b3224-998f-4d26-b31f-1899d97a3cc6"},{"origin":{"id":198688,"publication_date":"2023-03-23"},"id":951176,"name":"Updated Form to the Request 1FENG-G2023","file":{"id":1060406,"name":"Request for quotation_Feng_in vivo i ex vivo_2023.02.22_after correction.pdf","created_at":"2023-03-23 13:40:08","created_by":{"forename":"Ma\u0142gorzata","surname":"S\u0119ktas"},"uri":"/api/files/1060406"},"group_uuid":"f265aa3d-3fa4-43f6-a73d-899c45cf5a13"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}